Controlled ileal release budesonide in pediatric Crohn disease: Efficacy and effect on growth

Journal of Pediatric Gastroenterology and Nutrition

Volumn 33, Issue 1, 2001, Pages 75-80

  Kundhal, P ^a   Zachos, M ^a   Holmes, J L ^a   Griffiths, Anne M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Budesonide; Crohn disease; Growth

Indexed keywords

BUDESONIDE; CORTICOSTEROID;

ADOLESCENT; ARTICLE; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED DRUG RELEASE; CROHN DISEASE; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GROWTH DISORDER; HUMAN; ILEUM; MALE; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SCORING SYSTEM; WEIGHT GAIN;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BODY HEIGHT; BUDESONIDE; CROHN DISEASE; FEMALE; GROWTH; HUMANS; LONGITUDINAL STUDIES; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0034895029     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200107000-00013     Document Type: Article

References (41)

1. Growth and clinical course of children with Crohn's disease
2. Longitudinal growth in children and adolescents with inflammatory bowel disease
3. Growth failure in children with inflammatory bowel disease: A prospective study
4. Growth and development in chronic inflammatory bowel disease
5. Inflammatory mediators and suppression of growth in paediatric chronic IBD
6. Growth failure occurs through a decrease in insulin-like growth factor-1 which is independent of undernutrition in a rat model of colitis
7. Nutritional basis of growth failure in children and adolescents with Crohn's disease
8. Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease
9. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease
10. A comparison of budesonide with prednisolone for active Crohn's disease
11. Oral budesonide is as effective as oral prednisolone in active Crohn's disease
12. Budesonide versus prednisone in the treatment of active Crohn's disease
13. Oral budesonide for active Crohn's disease
14. A comparison of budesonide and mesalamine for active Crohn's disease
15. Oral budesonide as maintenance treatment for Crohn's disease: A placebo-controlled dose-ranging study
16. Oral budesonide prolongs remission in ileocecal Crohn's disease
17. Oral budesonide as maintenance therapy in Crohn's disease - Results of a 12-month study
18. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease
19. Growth suppression by glucocorticoid therapy
20. Development and validation of a pediatric Crohn's disease activity index
21. Assessment of activity of pediatric Crohn's disease: Which index to use?
22. Management of paediatric Crohn's disease
23. Management of growth failure in Crohn's disease
24. Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease
25. Glucocorticoid effects on somatomedins and somatomedin inhibitors
26. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease
27. Longterm 6-mercaptopurine treatment in adolescents with Crohn's disease
28. 6-mercaptopurine and prednisone therapy for newly diagnosed pediatric Crohn's disease: A prospective multicenter placebo-controlled clinical trial
29. Meta-analysis of enteral nutrition as primary therapy of active Crohn's disease
30. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease
31. Influence of inhaled corticosteroids on growth: A pediatric endocrinologist's perspective
32. Adverse effects of inhaled budesonide (800 ug) on growth and collagen turnover in children with asthma: A double-blind comparison of once-daily versus twice-daily administration
33. Growth and the growth hormone axis in prepubertal children with asthma
34. Budesonide CIR capsules in children and adults with Crohn's disease: A pharmacokinetic and tolerability study
35. National Cooperative Crohn's Disease Study: Results of drug treatment
36. European Cooperative Crohn's Disease Study: Results of drug treatment
37. Semi-elemental diet versus prednisone in the treatment of acute Crohn's disease in children and adolescents
38. Budesonide in the treatment of Crohn's disease. A meta-analysis
39. A short-term study of chimeric monocloncal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
40. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (Infliximab) to maintain remission in Crohn's disease
41. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease